Loading candles…
Syncom Formulations, established in 1995, is a global pharmaceutical company engaged in the manufacture and marketing of a wide range of healthcare products. Its portfolio includes generic formulations, ethical drugs, and over-the-counter (OTC) products, serving both domestic and international markets. Operating primarily as a generic pharmaceutical player, the company has more than 400 registered products. Syncom Formulations exports its products to over 15 countries across Africa, Asia, and Latin America, contributing to its presence in these regions. The company operates within the pharmaceutical industry but does not have publicly listed shares or noted subsidiaries, founders, or key management information available.
| Results - FY25 |
| To consider and approve the financial results for the period ended March 31, 2025 and other business matters |
| 19 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.